$81.25 0.12 (+0.15%)
11/20/2009 4:01 PM

Edwards Lifesciences Corp (EW)

CAPS Rating: 1 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.

Current Price $81.25 Mkt Cap $4.6B
Open $81.06 P/E Ratio 20.75
Prev. Close $81.13 Div. (Yield) N/A (N/A)
Daily Range $80.80 - $81.39 Volume 253,151
52-Wk Range $44.76 - $81.99 Avg. Daily Vol. 429,000

EW News and Commentary

Caps

How do you think EW will perform vs the S&P 500?

Add Stock to Watchlist

All Members

92 Outperform
58 Underperform
 

All-Star Members

26 Outperform
32 Underperform
 

Wall Street

12 Outperform
1 Underperform
 

Top EW Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TrackRonBaron (< 20)
Submitted February 20, 2008

Ron Baron owns 5204400 shares of Edwards Lifesciences Corp.. As of September 30th, 2007 EW was up 33.87% over the last quarter, composed 1.27% of his portfolio, and he controlled 9.18% of the company.

0 Comments | Reply | Report this Post

socalsy (95.34)
Submitted May 06, 2008

Its recent runup makes it overvalued. It would have to grow earnings over 21% a year for the next 5 years to justify $55/share.

0 Comments | Reply | Report this Post
EW VS S&P 500 (SPY)

Fools bullish on EW are also bullish on:

Fools bearish on EW are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about EW.

Recs

0
Member Avatar LyndaGayl (36.86) Submitted: 11/3/2009 10:27:01 AM : Underperform Start Price: $77.43 EW Score: +0.10

On my screener as a short.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 10/20/2009 2:37:32 PM : Outperform Start Price: $71.27 EW Score: +13.75

navallier.investorplace.com rated: A and moneycentral.msn.com rated:9

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar marrd (79.73) Submitted: 3/23/2009 12:52:33 PM : Outperform Start Price: $60.86 EW Score: -4.52

One acronym says it all: THV. Edwards' SAPIEN Transcatheter Heart Valve is a revolutionary new heart valve surgery which makes it possible to replace a diseased valve without cracking the chest. In the short term, this allows patients who would otherwise die during invasive surgery (or in absence of surgery) another chance at life. In the long run, further innovation opens up use of the technology as a cosmetic advantage over open heart surgery. This device has been going through clinical trials in Europe on its way to FDA approval, and faces competition from similar valve replacement approaches by companies such as Medtronic (who recently bought CoreValve). EW is an estimated 2 years further along the track for FDA approval, which will give it the cushion it needs to generate a solid foothold in the market before competitive products are launched, allowing its revenue to grow at an impressive rate in the coming years.

Report this Post 0 Comments | Reply | Permalink
View All 12 Pitches »

Leaderboard

Find the members with the highest scoring picks in EW.

Score Leader

psycho3

psycho3 (< 20) Score: +103.89

The Score Leader is the member with the highest score across all their picks in EW.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
psycho3 < 20 2/22/2008 Outperform NS $43.13 +88.38% -15.50% +103.89
boomercj 28.79 2/13/2008 Outperform 1Y $44.40 +83.00% -16.28% +99.27
lmkwin1 < 20 4/2/2008 Outperform NS $45.57 +78.30% -17.32% +95.62
g0bbles 54.07 7/26/2007 Outperform 3W $47.00 +72.87% -21.92% +94.79
nightsinbear 76.59 8/2/2007 Outperform 5Y $47.02 +72.80% -21.51% +94.31
KidThings 83.48 8/22/2007 Outperform 3Y $47.00 +72.87% -21.10% +93.98
trustee74 97.28 12/8/2006 Outperform 5Y $46.60 +74.36% -17.54% +91.90
BuckyInSD < 20 12/4/2006 Outperform 3W $46.72 +73.91% -17.96% +91.87
joelima < 20 4/14/2008 Outperform 1Y $46.24 +75.71% -14.40% +90.12 1 Comment
trackingfund 82.81 10/15/2007 Outperform NS $49.53 +64.04% -25.84% +89.88
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWedbush < 20 7/28/2009 Underperform NS $65.97 +2.24% +8.42% +6.17 9/16/2009 @ $67.45
TrackRBCCapMkts 82.07 2/26/2009 Outperform NS $60.00 +35.42% +43.10% -7.68
TrackCanaccord 78.23 12/2/2008 Outperform NS $47.58 +70.77% +33.95% +36.82
TrackJPMorgan 73.67 8/7/2008 Underperform NS $55.00 +47.73% -11.76% -59.48
TrackStanfordRes 78.48 3/18/2008 Outperform NS $44.99 +80.60% -12.69% +93.28
TrackCarisandCo 76.69 3/7/2008 Outperform NS $43.45 +87.00% -13.00% +100.00
TrackCreditSuiss 90.95 11/7/2007 Outperform NS $50.25 +61.69% -23.74% +85.43
TrackPiperJaff 78.45 10/5/2007 Outperform NS $51.50 +57.77% -26.04% +83.81
TrackRichAster 91.02 9/30/2007 Outperform NS $49.31 +64.77% -24.86% +89.63 2 Comments
TrackEveillard 88.00 9/30/2007 Outperform NS $49.31 +64.77% -24.86% +89.63 1 Comment
TrackRonBaron < 20 9/30/2007 Outperform NS $49.31 +64.77% -24.86% +89.63 1 Comment
TrackCitigroup < 20 7/24/2007 Underperform NS $47.70 +9.54% -10.16% -19.70 4/23/2008 @ $52.25
TrackWachovia < 20 7/11/2007 Outperform NS $49.27 +64.91% -23.59% +88.50
TrackNeedham < 20 4/30/2007 Outperform NS $49.49 +64.17% -22.56% +86.74
TrackUBS 88.39 2/2/2007 Outperform NS $51.49 +57.80% -19.75% +77.54

Featured Broker Partners